dr. rule on searching for a biomarker indicating indolent mcl
Published 4 years ago • 130 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:00
dr. rule on standard of care in mcl
-
2:06
dr. rule on watching and waiting approach for mcl subset
-
1:26
dr. rule addresses questions on the watch-and-wait approach in mcl
-
1:23
dr. rule on the future treatment paradigm in mcl
-
0:59
dr. rule on the fda approval of zanubrutinib in mcl
-
0:57
dr. rule on treatment of young, fit patients with mcl
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
6:00
mantle cell lymphoma: improved prognosis
-
1:28
dr. rule on potential for car t-cell therapy in mcl
-
1:21
professor simon rule - differences in patient prognosis for mcl
-
1:41
dr. smith on frontline treatment options in mcl
-
46:33
understanding biomarker testing
-
1:34
dr. mckinney discusses the watch-and-wait approach in mcl
-
1:46
dr. shah discusses sequencing for mcl
-
4:54
options for upfront therapy in mcl
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
1:56
dr. rule on the role of btk inhibitors in mcl
-
2:06
the role of venetoclax in r/r mcl & options for patients who progress on venetoclax
-
9:09
mantle cell lymphoma - frontline management
-
19:58
new agents for mantle cell lymphoma
-
0:55
dr. wang on the evolution of treatment in mcl